About the TOMMORROW Study

The TOMMORROW study is a research study seeking to learn more about the earliest stages of Alzheimer’s disease (AD). This study is currently recruiting more than 5,000 healthy senior participants in approximately 50 study centers in North America, Europe, and Australia. The purpose of the study is twofold:

  • To study a new investigational test to see if it can predict the genetic risk for developing mild cognitive impairment (MCI) due to AD by examining two specific genes—APOE and TOMM40.
  • To test the safety and effectiveness of an investigational medication in delaying the first symptoms of MCI due to AD.

Study Sites

The TOMMORROW study is taking place in approximately 50 study centers in North America, Europe, and Australia.

CityStateZip
Phoenix AZ85006
Sun City AZ85351
San Diego CA92103
San Francisco CA94109
Long Beach CA90806
Delray Beach FL33445
Merritt Island FL32952
St. Petersburg FL33709
Port Orange FL32127
Lake Worth FL33449
Orlando FL32806
Weston FL33331
Fort Myers FL33912
Decatur GA30033
Atlanta GA30329
Iowa City IA52242
Elk Grove Village IL60007
Chicago IL60612
Chicago IL60640
Farmington Hills MI48334
St Louis MO63141
Durham NC27710
Concord NC28025
Marlton NJ08053
Las Vegas NV89106
New York NY10029
New York NY10019
Akron OH44320
Portland OR97210
Charleston SC29401
Cordova TN38018
Houston TX77030
Salt Lake City UT84106
Middleton WI53562